Laura V. Peralta-Adalid

México, D.F, C.P. 14269, D.F, C.P. 14269
Mexico, MEX 14269, Mexico

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications

Pramipexole promotes CD8+ regulatory T cell-dependent neuroprotection in Parkinson's disease patients.

Pramipexole promotes CD8+ regulatory T cell-dependent neuroprotection in Parkinson's disease patients.

Journal: Brain, behavior, and immunity
Published: December 18, 2025

Models of neuroprotection in Parkinson's disease: Exploring cellular, molecular, and microenvironmental targets.

Models of neuroprotection in Parkinson's disease: Exploring cellular, molecular, and microenvironmental targets.

Journal: Experimental neurology
Published: December 13, 2025

Genetic Variants in Cytokines IL-10 and IL-17A Are Associated with the Risk and Severity of Sporadic Parkinson's Disease in Mexican Patients.

Genetic Variants in Cytokines IL-10 and IL-17A Are Associated with the Risk and Severity of Sporadic Parkinson's Disease in Mexican Patients.

Journal: Life (Basel, Switzerland)
Published: August 19, 2025

Genetic changes in regulatory immune cells induced by pramipexole and rotigotine: implications for the treatment of Parkinson's disease.

Genetic changes in regulatory immune cells induced by pramipexole and rotigotine: implications for the treatment of Parkinson's disease.

Journal: Inflammopharmacology
Published: August 04, 2025

Association of a five-metabolite and early-symptom profile with Parkinson's disease and its clinical progression.

Association of a five-metabolite and early-symptom profile with Parkinson's disease and its clinical progression.

Journal: Scientific reports
Published: July 01, 2025

Neurodegeneration models in Parkinson's disease: cellular and molecular paths to neuron death.

Neurodegeneration models in Parkinson's disease: cellular and molecular paths to neuron death.

Journal: Behavioral and brain functions : BBF
Published: December 08, 2024

Modeling the Effect of Cannabinoid Exposure During Human Neurodevelopment Using Bidimensional and Tridimensional Cultures.

Modeling the Effect of Cannabinoid Exposure During Human Neurodevelopment Using Bidimensional and Tridimensional Cultures.

Journal: Cells
Published: November 07, 2024

Advanced clinical stage Parkinson's disease is linked to proinflammatory and regulatory blood cell populations.

Advanced clinical stage Parkinson's disease is linked to proinflammatory and regulatory blood cell populations.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: October 28, 2024

Immunomodulation as a treatment for parkinson's disease in current trials: a systematic review and meta-analysis.

Immunomodulation as a treatment for parkinson's disease in current trials: a systematic review and meta-analysis.

Journal: Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion
Published: July 18, 2024

Treating activated regulatory T cells with pramipexole protects human dopaminergic neurons from 6-OHDA-induced degeneration.

Treating activated regulatory T cells with pramipexole protects human dopaminergic neurons from 6-OHDA-induced degeneration.

Journal: CNS neuroscience & therapeutics
Published: March 05, 2024

Increased levels of regulatory T cells and IL-10-producing regulatory B cells are linked to improved clinical outcome in Parkinson's disease: a 1-year observational study.

Increased levels of regulatory T cells and IL-10-producing regulatory B cells are linked to improved clinical outcome in Parkinson's disease: a 1-year observational study.

Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: February 19, 2024

Progressive Supranuclear Palsy Syndrome: An Overview.

Progressive Supranuclear Palsy Syndrome: An Overview.

Journal: IBRO neuroscience reports
Published: December 26, 2023
Showing 1-12 of 41

Last Updated: 09/26/2026